Form D · Other
Neuron DC Inc
San Francisco, CA · CIK 0002083331
Offering snapshot reported Sep 2, 2025 · SEC filing
- Reported sold
- $4.5M Offering amount: $20M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 2, 2025 | Initial | $4,500,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-556415
Source: Form D, filed Sep 2, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom M. De Raedt | Director, Executive |
| Zaid Kahn | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2261 Market Street, Pmb 86347
San Francisco, CA, 94114
San Francisco, CA, 94114